CME (CME) Q2 2025 Earnings Call Transcript

CME Group reported record Q2 results, with revenue up 10% to $1.7 billion, adjusted operating income up 14% to a record $1.2 billion, and adjusted EPS up 16% to $2.96. Average daily volume hit a company-record 30.2 million contracts, while international volume rose 18% and retail new trader acquisition jumped 56%; management also cut 2025 adjusted operating expense guidance by $15 million to $1.635 billion. The company highlighted strong crypto, FX Spot+, BrokerTec, and tokenization momentum, while maintaining a large capital return program with $455 million in quarterly dividends and about $3 billion paid in the first half.

Analysis

The core read-through is that CME is converting a volatility-rich macro regime into recurring monetization faster than the market likely modeled. The bigger second-order effect is not just higher transaction activity; it is client mix improvement: retail, international, crypto, and collateral all broaden the monetization surface while keeping fixed costs comparatively sticky. That means incremental volume should continue to fall disproportionately to the bottom line unless the company reaccelerates cloud or product investment faster than expected.

The most interesting competitive signal is that CME is encroaching on adjacent liquidity pools without needing to win on raw price. FX Spot+, BrokerTec expansion, and tokenization are all attempts to pull more of the workflow into a CME-controlled ecosystem, which increases switching costs and raises the odds that banks and brokers use CME as a default risk-management layer rather than just an exchange. The NASDAQ license extension through 2039 quietly de-risks a major index franchise and removes a long-duration overhang on equity-index monetization.

The main risk is that the recent surge is partially driven by transitory uncertainty and basis dislocation; if tariff headlines stabilize, realized volatility could fall faster than open interest, pressuring RPC growth even as volumes remain healthy. But the more durable bull case is that retail onboarding and crypto adoption are still in early innings, so a moderation in macro volatility may not fully offset secular adoption. In other words, CME is increasingly less a pure volatility play and more a toll road on global participation in risk transfer.

Key Decisions for Investors

• Long CME into the next 1-2 quarters; use any post-earnings pullback as entry. Thesis: operating leverage plus capital returns should keep EPS revision momentum positive even if volumes normalize. Risk/reward is favorable as downside is cushioned by dividend yield and buyback optionality.
• Pair trade: long CME / short NDAQ over the next 3-6 months. CME has clearer near-term monetization of retail, crypto, and macro volatility, while NDAQ’s index-license economics are more mature and less levered to current dislocation.
• Add CME call spreads 6-9 months out rather than outright stock if you want convexity to another volatility spike. A renewed tariff/geopolitical flare-up or a crypto leg higher could drive another upside surprise, but the stock may not fully price the optionality yet.
• Use GOOGL as a secondary long only as a strategic optionality hedge, not a core trade. If the tokenization pilot becomes a real 2026 product, GOOGL benefits as infrastructure partner, but the monetization path is less direct than CME’s.
• Avoid chasing short-dated strength in CME if macro volatility mean-reverts. The most plausible air pocket is not earnings deterioration but multiple compression on fears that Q2 was peak activity.